The Investigational Fungal Cyp51 Inhibitor VT-1129 Demonstrates Potent In Vitro Activity against Cryptococcus neoformans and Cryptococcus gattii. 2016

Shawn R Lockhart, and Annette W Fothergill, and Naureen Iqbal, and Carol B Bolden, and Nina T Grossman, and Edward P Garvey, and Stephen R Brand, and William J Hoekstra, and Robert J Schotzinger, and Elizabeth Ottinger, and Thomas F Patterson, and Nathan P Wiederhold
Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Thein vitroactivities of the novel fungal Cyp51 inhibitor VT-1129 were evaluated against a large panel ofCryptococcus neoformansandCryptococcus gattiiisolates. VT-1129 demonstrated potent activities against bothCryptococcusspecies as demonstrated by low MIC50and MIC90values. ForC. gattii, thein vitropotency was maintained against all genotypes. In addition, significantly lower geometric mean MICs were observed for VT-1129 than for fluconazole againstC. neoformans, including isolates with reduced fluconazole susceptibility.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D003455 Cryptococcus neoformans A species of the fungus CRYPTOCOCCUS. Its teleomorph is Filobasidiella neoformans. Blastomyces neoformans,Debaryomyces neoformans,Filobasidiella neoformans,Lipomyces neoformans,Saccharomyces neoformans,Torula neoformans,Torulopsis neoformans,Cryptococcus neoformans var. grubii
D005656 Fungal Proteins Proteins found in any species of fungus. Fungal Gene Products,Fungal Gene Proteins,Fungal Peptides,Gene Products, Fungal,Yeast Proteins,Gene Proteins, Fungal,Peptides, Fungal,Proteins, Fungal
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D013777 Tetrazoles
D015507 Drugs, Investigational Drugs which have received FDA approval for human testing but have yet to be approved for commercial marketing. This includes drugs used for treatment while they still are undergoing clinical trials (Treatment IND). The main heading includes drugs under investigation in foreign countries. Investigational Drug,Investigational New Drug,Investigational New Drugs,Investigational Drugs,Drug, Investigational,Drug, Investigational New,Drugs, Investigational New,New Drug, Investigational,New Drugs, Investigational
D015725 Fluconazole Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS. Apo-Fluconazole,Béagyne,Diflucan,Fluc Hexal,FlucoLich,Flucobeta,Fluconazol AL,Fluconazol AbZ,Fluconazol Stada,Fluconazol von ct,Fluconazol-Isis,Fluconazol-ratiopharm,Flunazul,Fungata,Lavisa,Loitin,Neofomiral,Oxifungol,Solacap,Triflucan,UK-49858,Zonal,Apo Fluconazole,Fluconazol Isis,Fluconazol ratiopharm,UK 49858,UK49858
D015870 Gene Expression The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION. Expression, Gene,Expressions, Gene,Gene Expressions

Related Publications

Shawn R Lockhart, and Annette W Fothergill, and Naureen Iqbal, and Carol B Bolden, and Nina T Grossman, and Edward P Garvey, and Stephen R Brand, and William J Hoekstra, and Robert J Schotzinger, and Elizabeth Ottinger, and Thomas F Patterson, and Nathan P Wiederhold
August 2016, Antimicrobial agents and chemotherapy,
Shawn R Lockhart, and Annette W Fothergill, and Naureen Iqbal, and Carol B Bolden, and Nina T Grossman, and Edward P Garvey, and Stephen R Brand, and William J Hoekstra, and Robert J Schotzinger, and Elizabeth Ottinger, and Thomas F Patterson, and Nathan P Wiederhold
March 2019, Antimicrobial agents and chemotherapy,
Shawn R Lockhart, and Annette W Fothergill, and Naureen Iqbal, and Carol B Bolden, and Nina T Grossman, and Edward P Garvey, and Stephen R Brand, and William J Hoekstra, and Robert J Schotzinger, and Elizabeth Ottinger, and Thomas F Patterson, and Nathan P Wiederhold
June 2017, Medical mycology,
Shawn R Lockhart, and Annette W Fothergill, and Naureen Iqbal, and Carol B Bolden, and Nina T Grossman, and Edward P Garvey, and Stephen R Brand, and William J Hoekstra, and Robert J Schotzinger, and Elizabeth Ottinger, and Thomas F Patterson, and Nathan P Wiederhold
February 2018, The Journal of antimicrobial chemotherapy,
Shawn R Lockhart, and Annette W Fothergill, and Naureen Iqbal, and Carol B Bolden, and Nina T Grossman, and Edward P Garvey, and Stephen R Brand, and William J Hoekstra, and Robert J Schotzinger, and Elizabeth Ottinger, and Thomas F Patterson, and Nathan P Wiederhold
September 2015, European journal of medicinal chemistry,
Shawn R Lockhart, and Annette W Fothergill, and Naureen Iqbal, and Carol B Bolden, and Nina T Grossman, and Edward P Garvey, and Stephen R Brand, and William J Hoekstra, and Robert J Schotzinger, and Elizabeth Ottinger, and Thomas F Patterson, and Nathan P Wiederhold
September 2018, Antimicrobial agents and chemotherapy,
Shawn R Lockhart, and Annette W Fothergill, and Naureen Iqbal, and Carol B Bolden, and Nina T Grossman, and Edward P Garvey, and Stephen R Brand, and William J Hoekstra, and Robert J Schotzinger, and Elizabeth Ottinger, and Thomas F Patterson, and Nathan P Wiederhold
July 2015, The Journal of antibiotics,
Shawn R Lockhart, and Annette W Fothergill, and Naureen Iqbal, and Carol B Bolden, and Nina T Grossman, and Edward P Garvey, and Stephen R Brand, and William J Hoekstra, and Robert J Schotzinger, and Elizabeth Ottinger, and Thomas F Patterson, and Nathan P Wiederhold
March 2017, Antimicrobial agents and chemotherapy,
Shawn R Lockhart, and Annette W Fothergill, and Naureen Iqbal, and Carol B Bolden, and Nina T Grossman, and Edward P Garvey, and Stephen R Brand, and William J Hoekstra, and Robert J Schotzinger, and Elizabeth Ottinger, and Thomas F Patterson, and Nathan P Wiederhold
March 2008, Revista iberoamericana de micologia,
Shawn R Lockhart, and Annette W Fothergill, and Naureen Iqbal, and Carol B Bolden, and Nina T Grossman, and Edward P Garvey, and Stephen R Brand, and William J Hoekstra, and Robert J Schotzinger, and Elizabeth Ottinger, and Thomas F Patterson, and Nathan P Wiederhold
June 2006, FEMS yeast research,
Copied contents to your clipboard!